(Q51684920)

English

Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression.

scientific article published on 10 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

author name string

Naoki Iwamoto

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Britta Maurer

3

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Matthias Brock

4

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Elena Pachera

5

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Astrid Jüngel

6

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Maurizio Calcagni

7

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Renate E Gay

8

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Michael L Whitfield

9

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Jörg H W Distler

10

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Steffen Gay

11

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Oliver Distler

12

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

language of work or name

0 references

publication date

10 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

75

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

1

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

303-310

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Increased prevalence of symptomatic macrovascular disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Large vessel occlusive disease associated with CREST syndrome and scleroderma

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

uPAR: a versatile signalling orchestrator

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arterial injury

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic scl

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Evolution of microRNAs and their targets: are all microRNAs biologically relevant?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Prediction of mammalian microRNA targets

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNAs in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNAs in the pathogenesis of cancer

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNA array analysis of microRNAs related to systemic scleroderma.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Molecular subsets in the gene expression signatures of scleroderma skin

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Entrez Gene: gene-centered information at NCBI

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

miR-193b Regulates Mcl-1 in Melanoma

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNA therapeutics.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205326

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2014-205326

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

release_3ut5v7bghjh5zcnmx3nybvt7lq

1 reference

https://api.fatcat.wiki/v0/release/3ut5v7bghjh5zcnmx3nybvt7lq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 April 2018

http://europepmc.org/abstract/MED/25384965

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51684920&oldid=1838007888"